NVST Stock Surges 32% With A 6-day Winning Spree On Record Earnings Beat
Envista (NVST) – a developer and marketer of dental products and technologies – hit a 6-day winning streak, with cumulative gains over this period amounting to 32%. The company’s market cap has surged by about $1.2 Bil over the last 6 days and currently stands at $5.0 Bil.
The stock has YTD (year-to-date) return of 39.4% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Rally?
[1] Q4 2025 Earnings & Revenue Beat
- That 7% Jump In Akamai Shares Is More Than Just A Relief Rally
- McKesson Stock: A Compounding Engine Facing Its Critical Test
- This Strategy Pays You 8.2% While Lining Up NFLX At Bargain Prices
- Why Chevron Stock May Drop Soon
- Ralph Lauren Stock: A Compounding Engine Facing Its North American Test
- How Broadcom Ends Nvidia’s GPU Monopoly
- Reported EPS of $0.38 vs $0.32 estimate
- Revenue of $751M vs $680.25M estimate
- Impact: Stock reached a new 52-week high, Significant post-market trading increase
[2] Multiple Analyst Price Target Hikes
- Barclays raises target to $34
- Stifel raises target to $31
- Impact: Sustained upward price momentum, Increased institutional investor confidence
Opportunity or Trap?
Below is our take on valuation.
There are a few things to fear in NVST stock given its overall Weak operating performance and financial condition. This isn’t appropriately reflected in the stock’s Moderate valuation which is why we think it is Unattractive (For details, see Buy or Sell NVST).
But here is the real interesting point.
You are reading about this 32% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that have not surged yet.
Returns vs S&P 500
The following table summarizes the return for NVST stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | NVST | S&P 500 |
|---|---|---|
| 1D | 0.3% | -0.0% |
| 6D (Current Streak) | 32.1% | 0.3% |
| 1M (21D) | 29.4% | -0.5% |
| 3M (63D) | 50.9% | 1.6% |
| YTD 2026 | 39.4% | 1.4% |
| 2025 | 12.5% | 16.4% |
| 2024 | -19.8% | 23.3% |
| 2023 | -28.5% | 24.2% |
However, big gains can follow sharp reversals – but how has NVST behaved after prior drops? See NVST Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 101 S&P constituents with 3 days or more of consecutive gains and 52 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 23 | 40 |
| 4D | 56 | 5 |
| 5D | 9 | 3 |
| 6D | 3 | 1 |
| 7D or more | 10 | 3 |
| Total >=3 D | 101 | 52 |
Key Financials for Envista (NVST)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $2.6 Bil | $2.5 Bil |
| Operating Income | $314.9 Mil | $137.2 Mil |
| Net Income | $-100.2 Mil | $-1.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $682.1 Mil | $669.9 Mil |
| Operating Income | $46.3 Mil | $57.5 Mil |
| Net Income | $26.4 Mil | $-30.3 Mil |
While NVST stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.